Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.

Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.

Kidney Int. 2000 Aug;58(2):762-9.


Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.

Verdecchia P, Schillaci G, Reboldi GP, Sacchi N, Bruni B, Benemio G, Porcellati C.

Blood Press Monit. 2000 Jun;5(3):187-93.


Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.

Kidney Int. 2000 Feb;57(2):601-6.


[Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].

Goicolea I, Fernández González R, Piniés J, Garrido J, Martínez JM, Armenteros S, Moreno Carretero E.

Nefrologia. 2002;22(2):170-8. Spanish.


Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

Kidney Int. 2000 Feb;57(2):590-600.


Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.

Tylicki L, Rutkowski P, Renke M, Rutkowski B.

Am J Nephrol. 2002 Jul-Aug;22(4):356-62.


Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

Diabetes. 1997 Jul;46(7):1182-8.


Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH.

Kidney Int. 2003 May;63(5):1874-80.


Losartan titration versus diuretic combination in type 2 diabetic patients.

de Pablos-Velasco PL, Pazos Toral F, Esmatjes JE, Fernandez-Vega F, Lopez de la Torre ML, Pozuelo A, Ruilope LM.

J Hypertens. 2002 Apr;20(4):715-9.


Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy.

Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH.

Clin J Am Soc Nephrol. 2011 May;6(5):1025-31. doi: 10.2215/CJN.07590810. Epub 2011 Feb 24.


Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.

de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.

J Hum Hypertens. 2004 Mar;18(3):215-22.


Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.

Igarashi M, Hirata A, Kadomoto Y, Tominaga M.

Endocr J. 2006 Aug;53(4):493-501. Epub 2006 Jul 10.


Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J; Diabetics Exposed to Telmisartan and Enalapril Study Group.

N Engl J Med. 2004 Nov 4;351(19):1952-61. Epub 2004 Oct 31. Erratum in: N Engl J Med. 2005 Apr 21;352(16)1731.

Items per page

Supplemental Content

Write to the Help Desk